Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-012220

Chairman and CEO acquired 747 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KAZIMI A J Chairman and CEO 2023-08-16 Other acquisition 10b5-1 +65 $1.64 $107 5,716,218 D
KAZIMI A J Chairman and CEO 2023-08-17 Other acquisition 10b5-1 +65 $1.70 $111 5,716,283 D
KAZIMI A J Chairman and CEO 2023-08-18 Other acquisition 10b5-1 +65 $1.70 $111 5,716,348 D
KAZIMI A J Chairman and CEO 2023-08-21 Other acquisition 10b5-1 +65 $1.68 $109 5,716,413 D
KAZIMI A J Chairman and CEO 2023-08-22 Other acquisition 10b5-1 +65 $1.72 $112 5,716,478 D
KAZIMI A J Chairman and CEO 2023-08-23 Other acquisition 10b5-1 +65 $1.70 $111 5,716,543 D
KAZIMI A J Chairman and CEO 2023-08-24 Other acquisition 10b5-1 +27 $1.69 $46 5,716,570 D
KAZIMI A J Chairman and CEO 2023-08-25 Other acquisition 10b5-1 +65 $1.70 $111 5,716,635 D
KAZIMI A J Chairman and CEO 2023-08-28 Other acquisition 10b5-1 +65 $1.71 $111 5,716,700 D
KAZIMI A J Chairman and CEO 2023-08-29 Other acquisition 10b5-1 +70 $1.67 $117 5,716,770 D
KAZIMI A J Chairman and CEO 2023-08-30 Other acquisition 10b5-1 +65 $1.68 $109 5,716,835 D
KAZIMI A J Chairman and CEO 2023-08-31 Other acquisition 10b5-1 +65 $1.67 $109 5,716,900 D
Loading xslF345X05/marketforms-62530.xml…